BenQ Medical Technology Corporation (TPEX:4116)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
39.20
-0.10 (-0.25%)
Aug 19, 2026, 1:30 PM CST

BenQ Medical Technology Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
117.6978.17104.83114.58180.2428.84
Depreciation & Amortization
257.48263.91249.51224.45222.0397.07
Other Amortization
5.225.225.714.784.233.97
Loss (Gain) From Sale of Assets
-17.27-17.250.90.03-3.85-0.06
Loss (Gain) From Sale of Investments
-66.46-8.8--5.13--
Loss (Gain) on Equity Investments
----5.55-3.44-1.79
Provision & Write-off of Bad Debts
4.343.590.370.871.44-
Other Operating Activities
178.2140.65118.59146.57118.1217
Change in Accounts Receivable
-62.51-55.97-7.33-1.45-90.49-4.73
Change in Inventory
-51.39-120.56-191.85-40.811.32-7.07
Change in Accounts Payable
-37.96-32.4159.13-26.4240.292.99
Change in Unearned Revenue
-4.285.83-3.03-23.7930.93-
Change in Other Net Operating Assets
81.0796.37-114.6154.21-17.99-14.88
Operating Cash Flow
404.12358.75222.22442.35482.84121.35
Operating Cash Flow Growth
33.50%61.44%-49.76%-8.39%297.90%-19.89%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-58.26-93.91-170.09-133.47-76.89-30.26
Sale of Property, Plant & Equipment
92.1285.378.095.4525.60.43
Cash Acquisitions
-3.72-24.43-23.26-76.24-
Sale (Purchase) of Intangibles
-9.84-5.34-5.4-5.81-2.94-2.67
Investment in Securities
-231.61-43.668.59-128.68-140.67-62.99
Other Investing Activities
-17.032.15-11.15-16.47-6.88-3.28
Investing Cash Flow
-228.33-79.76-133.22-278.98-125.54-98.77

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-313.47134.23-73.85-
Long-Term Debt Issued
-540316.09871235360
Total Debt Issued
890.8853.47450.32871308.85360
Short-Term Debt Repaid
----14.6--29.96
Long-Term Debt Repaid
--844.67-313.46-519.35-266.36-168.83
Total Debt Repaid
-926.85-844.67-313.46-533.95-266.36-198.8
Net Debt Issued (Repaid)
-36.058.8136.86337.0642.49161.2
Common Dividends Paid
-73.53-73.53-89.13-165.61-77.14-44.57
Other Financing Activities
-104.09-126.47-109.11-484.01-58.92-24.49
Financing Cash Flow
-213.68-191.2-61.38-312.57-93.5692.15

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
41.95-1.665.06-0.0718.320.07
Net Cash Flow
4.0786.1432.68-149.28282.05114.8

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
345.86264.8452.14308.88405.9591.09
Free Cash Flow Growth
97.07%407.99%-83.12%-23.91%345.66%-20.84%
Free Cash Flow Margin
6.35%5.04%1.09%6.80%9.28%6.22%
Free Cash Flow Per Share
7.705.911.166.899.052.04
Levered Free Cash Flow
-194.02-161.18-8.6224.2-135.7671.13
Unlevered Free Cash Flow
-165.19-133.6612.79241.66-124.6173.57

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
45.4843.1634.0127.8317.583.86
Cash Income Tax Paid
121.68116.01112.08109.9365.2916.24
Change in Working Capital
-75.08-106.75-257.69-38.25-35.94-23.68